Quadrature Capital »

Taysha Gene Therapies shares owned by Quadrature Capital

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Quadrature Capital from 13F filings

Historical chart of Quadrature Capital investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Quadrature Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Quadrature Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $105k 24k 4.47

More positions owned by Quadrature Capital

Asml Hldg Nv N Y Registry Shs (ASML)
UnitedHealth (UNH)
Spdr Gold Tr Gold Shs (GLD)
Sap Se Spon Adr (SAP)
Micron Technology (MU)
Sandisk Corp (SNDK)
Advanced Micro Devices (AMD)
Tesla Motors (TSLA)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Circle Internet Group Com Cl A (CRCL)
Crowdstrike Hldgs Cl A (CRWD)
Intel Corporation (INTC)
Toronto Dominion Bk Ont Com New (TD)
Select Sector Spdr Tr State Street Ene (XLE)

View all positions for Quadrature Capital

Top funds holding Taysha Gene Therapies

RA Capital Management
Goldman Sachs Group
venBio Select Advisor
BlackRock
Vestal Point Capital
Morgan Stanley
FMR
Rtw Investments
State Street Corporation
Vanguard Capital Management
Octagon Capital Advisors
Siren
Polar Capital Holdings
Geode Capital Management
D. E. Shaw & Co

View all funds holding Taysha Gene Therapies